Siren, L.L.C. Iovance Biotherapeutics, Inc. Transaction History
Siren, L.L.C.
- $2.26 Trillion
- Q4 2024
A detailed history of Siren, L.L.C. transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Siren, L.L.C. holds 1,106,040 shares of IOVA stock, worth $4.23 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
1,106,040
Previous 1,106,040
-0.0%
Holding current value
$4.23 Million
Previous $10.4 Billion
21.19%
% of portfolio
0.36%
Previous 0.52%
Shares
1 transactions
Others Institutions Holding IOVA
# of Institutions
343Shares Held
247MCall Options Held
2.51MPut Options Held
3.5M-
Vanguard Group Inc Valley Forge, PA27.5MShares$105 Million0.0% of portfolio
-
Mhr Fund Management LLC New York, NY24.4MShares$93.3 Million24.02% of portfolio
-
Perceptive Advisors LLC New York, NY22.1MShares$84.5 Million5.46% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$81.1 Million0.0% of portfolio
-
State Street Corp Boston, MA12.2MShares$46.8 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $603M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...